SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

Cogent Biosciences: Ended Q4 2020 With $242.2 M in Cash, Funding Ops Into 2024 >COGT

Cogent Biosciences: Ended Q4 2020 With $242.2 M in Cash, Funding Ops Into 2024 >COGT

· 03/16/2021 07:02

Please log in to view news